CG
ARIA

Colony Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Colony Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$4K – 946
2015
Q2 		$4K Buy
+500
New +$4.42K ﹤0.01% 671
2015
Q1 		– Sell
-243
Closed -$2K – 838
2014
Q4 		$2K Hold
243
– – ﹤0.01% 707
2014
Q3 		$1K Sell
243
-5,000
-95% -$29.2K ﹤0.01% 769
2014
Q2 		$33K Hold
5,243
– – ﹤0.01% 376
2014
Q1 		$42K Hold
5,243
– – 0.01% 354
2013
Q4 		$36K Buy
+5,243
New +$28.3K 0.01% 359

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Colony Group's ARIA Position: Q3 2015 in Review

Colony Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2015, closing a stake of 500 shares — an estimated $4K sold.

Colony Group first reported a position in ARIA in Q4 2013 and held it in 6 quarters. The position peaked at $42K in Q1 2014. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

  • Colony Group reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Colony Group sold 500 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $4K.
  • Colony Group first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Colony Group's Ariad Pharmaceuticals Inc position peaked at $42K in Q1 2014.
  • 175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on Colony Group's 13F filing for Q3 2015, filed 16 Nov 2015.